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I
nfections are a growing cause of acute kidney 
injury (AKI) and have attracted attention in 
recent years due to outbreaks of zoonotic dis-
eases. A rise in AKI events occurred during 
the outbreak of influenza in 2009 and the hemo-
lytic uremic syndrome in 2011 in Germany.1,2 In 
2012 Germany’s authorities noticed a remark-
able increase of hantavirus-induced AKI. Han-
taviruses are zoonoses transmitted by inhalation 
of contaminated aerosols from small mammals. 
Pathogenic strains are distributed worldwide 
and cause different clinical entities. In Europe, 
the Puumala hantavirus is predominant, and the 
epidemic occurrence of cases has been increasing 
in recent years. This year, an extraordinary rise 
has been observed; case numbers exceed those 
of previous years. The problem of increasing case 
numbers is not limited to Germany. In September 
2012 an outbreak of hantavirus occurred in the 
Unites States. However, the situation there differs 
from those in European countries. The disease-
causing hantavirus, Sin Nombre, is the etiological 
agent of hantavirus cardiopulmonary syndrome, 
characterized by pulmonary involvement and 
high mortality. The outbreak occurred among 
tourists in a national park. A global alert was 
issued, because thousands of travelers from for-
eign countries were at risk of having acquired the 
infection during their stay in the park. The two 
outbreaks reported here are not epidemiologically 
linked but demonstrate the global emergence of 
hantavirus disease.
Epidemiological characteristics of the  
current outbreak in Germany
Since 2001 it has been mandatory to report a han-
tavirus infection to the health authorities in Ger-
many. During these years fewer than 450 cases 
per year were reported, with the exception of the 
outbreaks in 2007 and 2010, with 1688 and 2017 
cases, respectively.3
This year, 2182 cases of hantavirus disease were 
already reported from January to July (Figure 1). 
The number of infections started to increase from 
October 2011, and since spring 2012, cases have 
rapidly accumulated. Males are overrepresented 
and constitute about 70% of cases. The age group 
that is mostly infected ranges from 40 to 49 years. 
These characteristics correspond to those of pre-
vious hantaviral epidemics.
Transmission and clinical course of Puumala 
hantavirus disease
In Germany, Puumala virus (PUUV) is clinically 
the most important hantavirus. Its natural reservoir 
is the bank vole, Myodes glareolus, which is found 
throughout the country. PUUV disease cases in 
Germany are concentrated in specific outbreak 
regions (Figure 2), each of them characterized by a 
particular molecular clade of PUUV strains found 
in local bank voles as well as patients.4,5
The initial symptoms of hantavirus disease are 
sudden onset with fever, nausea, headache, and 
abdominal and side/back pain. About 55–65% of 
patients with hantavirus disease are hospitalized, 
for a median duration of 8 days. Patients are usually 
admitted with acute renal failure and thrombocy-
topenia. Infection is characterized by marked pro-
teinuria, elevation of serum creatinine levels, and 
decreased serum albumin. Typically, hemorrhagic 
fever with renal syndrome is diagnosed serologi-
cally by immunofluorescence assay, immunoblot, 
or enzyme-linked immunosorbent assay. Because 
the viremic phase in the patient lasts no longer 
than 1 to a few weeks after the onset of symptoms, 
the molecular characterization of circulating virus 
strains by sequencing of the hantavirus genome is 
possible only from serum/EDTA blood specimens 
sampled during this period. In contrast to sero-
logical assays, molecular approaches make it pos-
sible to distinguish between infections by different 
representatives of a particular hantavirus species 
(for instance, PUUV). Efficient serotyping of the 
responsible hantavirus species requires the deter-
mination of neutralizing antibodies in the patient’s 
serum, which has to be performed under biosafety 
level 3 conditions.6
About 5% of hospitalized patients require 
temporary dialysis. In some cases, extrarenal 
manifestations such as neurological complications 
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and pulmonary symptoms can be observed. PUUV 
infections may vary in severity and symptoms. The 
prognosis regarding renal outcome is very good, 
and most patients recover completely. No fatal 
cases were reported during the ongoing outbreak. 
The case fatality rate for infection with PUUV 
is very low in Europe (<0.1%) and Germany 
(<0.03%). Of the 8141 hantavirus cases reported 
in Germany since 2001, only two were fatal.7
Surveillance and prevention
In Germany, hantavirus disease has to be reported 
by law.8 There are no licensed prophylactic vac-
cines for use in Europe and no passive immuniza-
tion or chemoprophylaxis available. Consequently, 
exposure prophylaxis is the most important task 
for prevention of hantavirus infections and dis-
ease. To reduce the risk of virus transmission 
from the reservoir hosts to humans, one should 
avoid any kind of contact with small rodents (and 
probably shrews) or exposure to their excreta. 
This includes control of mice inside and outside 
of human housing. Trapped or dead mice have 
to be disinfected and disposed of. When clean-
ing rooms with potential mouse infestation (such 
as stables, sheds, summer houses in spring), one 
should wear disposable gloves and, if possible, 
a face mask. Swirling dust particles containing 
mouse excreta or nesting material should be 
avoided. Areas frequented by rodents should be 
moistened before cleaning. During outdoor activi-
ties (camping, farm or forest work), contact with 
nests and excreta of mice should also be avoided. 
Further precautions include the safe storage of 
food inside and outside of human dwellings and 
the avoidance of food litter.6
Epidemic situation in other European countries
According to a standardized prioritization pro-
cedure for infectious diseases based on criteria 
such as clinical importance, epidemiology, and 
impact on society, hantavirus disease was clas-
sified in the highest priority group for necessary 
surveillance and epidemiology research.9 More 
than 80,000 cases of hantavirus disease were 
reported in the past 10 years in Europe;10 the 
highest case numbers were in Russia, Finland, 
Germany, Sweden, Belgium, and France, with 
annual averages ranging from about 100 (France) 
to more than 7000 (Russia). In 2012, increased 
case numbers were also observed in France and 
Russia. The epidemic profile of hantavirus disease 
in the European countries is heterogeneous and 
closely linked to conditions that favor growth of 
infected reservoir host populations (for example, 
climate, abundance of food, lack of predators).11
Hantavirus outbreak in the United States
At the time of writing, an outbreak of hantavi-
rus infections affected California. From June 
through 17 September 2012, nine cases of han-
tavirus pulmonary syndrome were reported 
in people who had visited Yosemite National 
Park, California.12 Three people died from the 
infection. In contrast to the outbreak of han-
tavirus disease in Germany, whose clinical 
picture is characterized by acute kidney injury 
and associated with a favorable outcome, peo-
ple infected in Yosemite developed severe lung 
disease. Species circulating in the Americas 
cause hantavirus cardiopulmonary syndrome 
(HCPS).13 In North America, including Yosem-
ite National Park, the Sin Nombre hantavirus 
carried by the deer mouse (Peromyscus man-
iculatus) is a predominant species. As with 
hantavirus species of the Old World, person-
to-person transmission of Sin Nombre virus 
has not been reported. HCPS is characterized 
by a sudden onset with flu-like symptoms. After 
the initial phase, respiratory distress and hemo-
dynamic alterations occur, leading to hypoten-
sion, pulmonary edema, and hypoxia. Patients 
often require supplemental oxygen. The mortal-
ity of HCPS is 35%. In contrast to species in the 
Old World, the renal involvement is minimal. 
Mild to moderate elevation of serum creatinine 
and proteinuria are observed.14,15 In addition 
to the modest renal dysfunction that affects 
some HCPS patients, potential renal sequelae 
have been reported.16 However, no apparent 
pathology of the kidney is observed.
Figure 1 | Monthly distribution of reported cases of 
hantavirus disease in Germany (2001–July 2012). 
Outbreaks occurred seasonally, with a marked increase 
in 2007, 2010, and 2012. The increase of cases of the 
ongoing outbreak started in October 2011 (brown line, 
marked with an arrow). (Source: SurvStat, Robert-Koch-
Institut, www3.rki.de/SurvStat, 17 September 2012.)
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Yosemite National Park is a popular travel 
destination, attracting more than 4 million 
tourists a year from all over the world. Eight 
of the nine infected people stayed in so-called 
signature tent cabins in Curry Village. An esti-
mated 10,000 people stayed in these cabins from 
10 June through 24 August 2012. About 2500 
were from outside the United States, most of 
them from Europe; 1923 European Union citi-
zens were potentially exposed to the virus. The 
greatest numbers were from France (502), the 
United Kingdom (342), and Germany (250). 
Fortunately, despite the great number of people 
potentially exposed, no other infected Yosemite 
visitors from inside or outside the United States 
were reported. Import of hantavirus infection 
owing to travel is seldom observed. Only one 
case of HCPS imported from the Americas to 
Europe is known to have occurred, from South 
America in 2001.17 The outbreak of HCPS 
among travelers calls for an awareness that 
imported hantavirus disease may present dif-
ferently than what is expected from the endemic 
hantavirus strain. In contrast to the hantavi-
rus disease in Germany and other European 
and Asian countries, HCPS is a rare disease, 
with less than 300 cases in the past 10 years 
in the United States. However, increasing case 
numbers in Europe and the outbreak of a han-
tavirus infection with a high mortality among 
travelers bring hantavirus disease into the focus 
of public-health interest.
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Figure 2 | Geographical distribution of Puumala 
hantavirus cases in Germany, January–July 2012. 
(Source: SurvStat, Robert-Koch-Institut, www3.rki.de/
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